Do we need immunohistochemistry to evaluate sentinel lymph nodes in vulvar cancer?

Gynecologic Oncology

Volumn 111, Issue 1, 2008, Pages 158-

  Tamussino, Karl ^a   Bader, Arnim A ^a   Regauer, Sigrid ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

EOSIN; HEMATOXYLIN;

CANCER STAGING; HUMAN; IMMUNOHISTOCHEMISTRY; INGUINAL LYMPH NODE; LETTER; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MICROMETASTASIS; PRIORITY JOURNAL; PROGNOSIS; RECURRENT DISEASE; SENTINEL LYMPH NODE; SQUAMOUS CELL CARCINOMA; VULVA CANCER;

CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODES; SENTINEL LYMPH NODE BIOPSY; VULVAR NEOPLASMS;

EID: 52049121603     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2008.05.009     Document Type: Letter

References (4)

1. Moore R.G., Robison K., Brown A.K., DiSilvestro P., Steinhoff M., Noto R., et al. Isolated sentinel lymph node dissection with conservative management in patients with squamous cell carcinoma of the vulva: a prospective trial. Gynecol Oncol 109 (2008) 65-70
2. Moore R.G., Granai C.O., Gajewski W., Gordinier M., and Steinhoff M.M. Pathologic evaluation of inguinal sentinel lymph nodes in vulvar cancer patients: a comparison of immunohistochemical staining versus ultrastaging with hematoxylin and eosin staining. Gynecol Oncol 91 (2003) 378-382
3. Terada K.Y., Shimizu D.M., and Wong J.H. Sentinel node dissection and ultrastaging in squamous cell cancer of the vulva. Gynecol Oncol 76 (2000) 40-44
4. Van der Zee A.G.J., Oonk M.H., De Hullu J.A., Ansink A.C., Vergote I., Verhijen R.H., et al. Sentinel node dissection is safe in the treatment of early-stage vulvar cancer. J Clin Oncol 26 (2008) 884-889